{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:35:45Z","timestamp":1760834145287,"version":"build-2065373602"},"reference-count":21,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"China Preventive Medicine Association","award":["840"],"award-info":[{"award-number":["840"]}]},{"name":"Medical Research Fund of Guangdong Provincial People's Hospital","award":["8200060682"],"award-info":[{"award-number":["8200060682"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,11,22]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Multimodal anticancer therapies greatly damage the fertility of breast cancer patients, which raises urgent demand for fertility preservation. The standard options for fertility preservation are oocyte and embryo cryopreservation; both require controlled ovarian hyperstimulation (COH). However, there are safety concerns regarding breast cancer relapse due to the elevated serum estradiol levels during COH. Serum estradiol levels can be effectively decreased with the highly specific aromatase inhibitor letrozole. Letrozole is still uncommonly used during COH for fertility preservation, which has only been reported in a few studies, and the evidence of oocyte retrieval during ovarian stimulation and short-term safety from the perspective study is insufficient. As a result, this study will compare the efficacy of ovarian stimulation and the short-term safety of letrozole COH and non-letrozole COH protocols for preserving fertility in patients with breast cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This is an open-label, multicentre RCT being conducted in five Chinese reproductive medical centres. 64 eligible patients diagnosed with breast cancer will be randomly assigned (1:1) to the letrozole or non-letrozole group during their COH cycles. The primary outcome is the number of mature oocytes. The secondary outcomes are the number of high-quality embryos, incidence of ovarian hyperstimulation syndrome(OHSS) and recurrence rate of breast cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>Ethical approval was obtained from the Ethics Review Committee of Guangdong Provincial People\u2019s Hospital (KY-Q-2023-840-02). Written informed consent will be obtained from each participant. Findings will be disseminated to patients, clinicians and commissioning groups through peer-reviewed publications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ChiCTR2300078625<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-083943","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T21:35:11Z","timestamp":1737408911000},"page":"e083943","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: study protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1080-7479","authenticated-orcid":false,"given":"Yanqiu","family":"Xie","sequence":"first","affiliation":[{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"},{"name":"Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Women and Children's Hospital, School of Medicine, Xiamen university, Xiamen, Fujian, China"},{"name":"Xiamen Key Laboratory of Reproduction and Genetics, Xiamen, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifen","family":"Deng","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Shenzhen Hengsheng Hospital, Shenzhen, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Fan","sequence":"additional","affiliation":[{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"},{"name":"Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"},{"name":"Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajing","family":"Kang","sequence":"additional","affiliation":[{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"},{"name":"Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"},{"name":"Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7413-4031","authenticated-orcid":false,"given":"Yuhua","family":"Shi","sequence":"additional","affiliation":[{"name":"Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China"},{"name":"Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China"},{"name":"Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"2025101810495620000_15.1.e083943.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2025101810495620000_15.1.e083943.2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10549-016-3947-0","article-title":"Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence","volume":"159","author":"Li","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"2025101810495620000_15.1.e083943.3","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-364","article-title":"A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China","volume":"11","author":"Li","year":"2011","journal-title":"BMC Cancer"},{"key":"2025101810495620000_15.1.e083943.4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.21147\/j.issn.1000-9604.2019.04.09","article-title":"Changing patterns and survival improvements of young breast cancer in China and SEER database, 1999-2017","volume":"31","author":"Guo","year":"2019","journal-title":"Chin J Cancer Res"},{"key":"2025101810495620000_15.1.e083943.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.1914"},{"key":"2025101810495620000_15.1.e083943.6","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/humrep\/deac035","article-title":"Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis","volume":"37","author":"Arecco","year":"2022","journal-title":"Hum Reprod"},{"key":"2025101810495620000_15.1.e083943.7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cncr.32546","article-title":"Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation","volume":"126","author":"Letourneau","year":"2020","journal-title":"Cancer"},{"key":"2025101810495620000_15.1.e083943.8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex027"},{"key":"2025101810495620000_15.1.e083943.9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/humrep\/deaa029","article-title":"Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study","volume":"35","author":"Marklund","year":"2020","journal-title":"Hum Reprod"},{"key":"2025101810495620000_15.1.e083943.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.05.007"},{"key":"2025101810495620000_15.1.e083943.11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.037"},{"key":"2025101810495620000_15.1.e083943.12","doi-asserted-by":"crossref","first-page":"121074","DOI":"10.1016\/j.lfs.2022.121074","article-title":"Letrozole: Pharmacology, toxicity and potential therapeutic effects","volume":"310","author":"Mukherjee","year":"2022","journal-title":"Life Sci"},{"key":"2025101810495620000_15.1.e083943.13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.rbmo.2021.08.003","article-title":"Fertility preservation for women with breast cancer before chemotherapy: a systematic review and meta-analysis","volume":"44","author":"Chen","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"2025101810495620000_15.1.e083943.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0962"},{"key":"2025101810495620000_15.1.e083943.15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1933719117728800","article-title":"Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes","volume":"25","author":"Turan","year":"2018","journal-title":"Reprod Sci"},{"key":"2025101810495620000_15.1.e083943.16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2022.07.017","article-title":"Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study","volume":"174","author":"Goldrat","year":"2022","journal-title":"Eur J Cancer"},{"key":"2025101810495620000_15.1.e083943.17","article-title":"Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients","volume":"4","author":"Sonigo","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"2025101810495620000_15.1.e083943.18","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/deac145","article-title":"Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols","volume":"37","author":"Balkenende","year":"2022","journal-title":"Hum Reprod"},{"key":"2025101810495620000_15.1.e083943.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.8700"},{"key":"2025101810495620000_15.1.e083943.20","first-page":"387","article-title":"Expert consensus on the diagnosis and treatment of young breast cancer in China (2022 Edition)","volume":"103","year":"2023","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2025101810495620000_15.1.e083943.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-083943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:50:04Z","timestamp":1760809804000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-083943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,20]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjopen-2024-083943"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-083943","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}